Reuters logo
2 months ago
BRIEF-Calithera announces clinical data from product candidate CB-1158
June 5, 2017 / 10:56 AM / 2 months ago

BRIEF-Calithera announces clinical data from product candidate CB-1158

June 5 (Reuters) - Calithera Biosciences Inc:

* Calithera Biosciences Inc - clinical data from its product candidate CB-1158, a first-in-class arginase inhibitor​

* Calithera Biosciences Inc - ‍CB-1158 was generally well tolerated with no drug-related serious adverse events​

* Calithera Biosciences Inc - ‍no grade 3 treatment related adverse events were reported.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below